Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie 15. April 2026
Suchen
Gastroplattform
Neoplasie
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Magen-Darm
Oesophagus
Motilitätsstörungen
Neoplasie
Anderes
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1931  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 38615  
   
Comparison of overall survival across treatment modalities for oesophageal, gastroesophageal, and gastric cancer: protocol for a systematic review and network meta-analysis.
Syst Rev
Apostolidou-Kiouti F, Haidich AB, Mavridis D, Apostolaki AI, Tsavdaris D, Nikolakopoulou A.
PMID: 41981647 [PubMed - as supplied by publisher]


Global burden of esophageal cancer attributable to smoking and alcohol, 1990-2021, with projections to 2040: a population-based analysis of the global burden of disease study 2021.
Ann Med
Zhou H, Wu J, Yin Y.
PMID: 41980036 [PubMed - indexed for MEDLINE]


Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study.
Ann Surg Oncol
Sugase T, Kanemura T, Matsuura N, Yamamoto K, Ushimaru Y, Masuike Y, Yanagimoto Y, Yamamoto K, Sakano Y, Mori R, Kitakaze M, Kubo M, Fukuda Y, Komatsu H, Miyo M, Sueda T, Kagawa Y, Gotoh K, Kobayashi S, Miyata H.
PMID: 41979848 [PubMed - as supplied by publisher]


Computational-based integrative methylome-transcriptome analysis reveals widespread enhancer hypomethylation in esophageal carcinoma.
Epigenomics
Ali A, Din TADAAT, Jalal MIA, Arifin WN, Abusalah MAHA, Abuarqoub AH, Ahmed N.
PMID: 41979132 [PubMed - as supplied by publisher]


Impact of adjuvant therapy on survival in esophageal cancer patients after neoadjuvant therapy investigated by a population based cohort study.
Sci Rep
Huang JL, Lin ZX, Zeng KY, Lu Z, Lin XP, Wang HR, Xie YW, Yang JR.
PMID: 41974750 [PubMed - as supplied by publisher]


Identification of a Novel Disulfidptosis-Related Five-Gene Signature for Prognostic Prediction and Immune Characterization in Esophageal Cancer.
Biology (Basel)
Chen Y, Li X, Jiang H, Liu X, Ma N, Wang X.
PMID: 41972548 [PubMed]


Immune Evasion of Helicobacter pylori and Extra-Gastric Cancer Risk.
J Gastroenterol Hepatol
Engin ED, Engin AB, Engin A.
PMID: 41972361 [PubMed - as supplied by publisher]


The construction of CD8+ T cell-associated molecular subtypes in esophageal squamous cell carcinoma reveals tumor heterogeneity, tumor microenvironment, and immunotherapy.
Front Immunol
Cao S, Jiang H, Li Y, Yang K, Tian L, Li L.
PMID: 41972154 [PubMed - indexed for MEDLINE]


Survival benefit and dynamics of CD8(+) T cells and tumor-associated macrophages in neoadjuvant immunochemotherapy vs. chemotherapy for locally advanced esophageal squamous cell carcinoma: an IPTW-adjusted real-world study.
Front Immunol
Gan Y, Li Y, Fang L, Chen Y, Yang D.
PMID: 41972149 [PubMed - indexed for MEDLINE]


Prognostic prediction in nasopharyngeal carcinoma using multi-region interaction features based on MRI habitat analysis.
Quant Imaging Med Surg
Liu P, Li H, Chen S, Chen S, Zhou H, Ruan G, Luo M, Liu L, Chen H.
PMID: 41972088 [PubMed]


Computational Approach Improves Diagnostic Performance Based on Tumor-Associated Autoantibodies in Esophageal Squamous Cell Carcinoma.
Comput Struct Biotechnol J
Nojima Y, Shiratori F, Suzuki T, Yajima S, Toyozumi T, Shimada H.
PMID: 41971943 [PubMed]


Communicating clinical trial information about cancer drug products to patients and healthcare professionals: review of patient-reported outcome messaging.
BMJ Oncol
Shahraz S, Wong OY, Chotai R, Knight S, Globe D, Patel MJ, Kaushik A, Aiyegbusi OL, Calvert M.
PMID: 41971155 [PubMed]


Esophageal myotomy and risk of esophageal cancer and mortality in achalasia: Real-world cohort study.
Endosc Int Open
Jaber F, Ibrahim MA, Jaber M, Soliman Y, Khalaf MA, Keihanian T, Ayoub F, Othman MO, Jawaid S.
PMID: 41970688 [PubMed]


Self-assembling peptide hydrogel prevents esophageal stenosis after endoscopic submucosal dissection for esophageal squamous cell carcinoma: Multicenter prospective study.
Endosc Int Open
Urabe Y, Hiyama Y, Asayama N, Tamaru Y, Sanomura Y, Yoshida S, Nagata S, Hiraga Y, Takamori A, Orihashi Y, Kuwai T, Oka S.
PMID: 41970677 [PubMed]


Fivefold Cross-Validation Approach in Evaluating the Robustness of Machine Learning Models for Prediction of Esophageal Cancer.
Indian J Community Med
Kalita BK, Singh KA, Kalita M.
PMID: 41969709 [PubMed]


Near infrared fluorescence-guided lymphadenectomy during esophagectomy for esophageal squamous cell carcinoma.
Surgery
Singh S, Varshney VK, Rai A, Selvakumar B, Varshney P, Agarwal L, Soni S, Lal Birda C, Agarwal A.
PMID: 41967430 [PubMed - as supplied by publisher]


Impact of a diagnosis of 'low-grade dysplasia' in patients with Barrett's esophagus.
Dis Esophagus
Kung CH, Vissapragada R, Schloithe A, Bright T, Bulamu N, Watson D.
PMID: 41967026 [PubMed - indexed for MEDLINE]


The prevalence, nature and trajectory of oropharyngeal dysphagia within the first year following curative open resection for esophageal cancer.
Dis Esophagus
Hayes M, Gillman A, Elliott JA, Donohoe CL, Reynolds JV, Regan J.
PMID: 41967025 [PubMed - indexed for MEDLINE]


Event-free survival as a surrogate for overall survival in locally advanced esophageal cancer: a correlation analysis of trials assessing definitive chemoradiation therapies.
BMC Cancer
Xue W, Valderrama A, Ramakrishnan K, Zhou J, Meng Y, Bordia S, Shah MA.
PMID: 41963862 [PubMed - as supplied by publisher]


Deepath-SCC: a deep learning model for accurate tissue origin identification in squamous cell carcinoma.
NPJ Precis Oncol
Lu S, Pang Y, Wen H, Hu L, Zhou X, Yang X, Qi X, Liu C, Liu J, Qi P, Huang S, Xu Q, Sun Y, Wang Q.
PMID: 41963625 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 38615    Seite 1 von 1931  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1